Presentation of Prof. Capucine Morelot-Panzini on 20E (BIO101) for Severe COVID-19 at the ERS 2024 Conference in Vienna

Presentation of Prof. Capucine Morelot-Panzini on 20E (BIO101) for Severe COVID-19 at the ERS 2024 Conference in Vienna

During the recent European Respiratory Society (ERS) conference held in Vienna, Prof. Capucine Morelot-Panzini, Head of Pneumonology at Pitié-Salpêtrière Hospital and Professor at Sorbonne University, presented the positive results of the COVA phase 2/3 trial on 20-hydroxyecdysone (BIO101) for the treatment of hospitalized severe COVID-19 patients. Her presentation highlighted a statistically significant reduction in the…

MARCH 12, 2024

Biophytis announces its participation in several events in Europe and the United States over the coming months Biophytis outcomes for patients suffering from age-related diseases, has announced its participation in several conferences until the end of the first half of 2024. Annual scientific conference on sarcopenia Biophytis management will take part in the 14th International…

DECEMBER 11, 2023

Biophytis announces its participation in several conferences in Europe and the US during the first quarter of 2024 Biophytis management will be in San Francisco for meetings with potential partners and investors at the 42nd JP Morgan Healthcare Conference, to be held from 8 to 11 January 2024. In addition, the company will be present:…

OCTOBER 13, 2023

Next week, our CBO, Edouard Bieth, will be attending the Pharma Partnering Summit in Boston, US! 🇺🇸 Hope to meet you there to learn more about how Biophytis is contributing to the future of biotechnology and discuss potential partnership opportunities. To arrange a one-to-one meeting, please send a message directly to the following email address:…

SEPTEMBER 12, 2023

During the 25th annual H.C. Wainwright Global Investment Conference, Biophytis’ CEO Stanislas Veillet presented the company, its ambitions and the latest progress it made on its various projets. A replay will be available for 90 days at the following link: https://journey.ct.events/view/1037e68b-3f79-4b25-9a15-27affba4d7c4 Watch here

MAY 12, 2022

Biophytis announces its participation at the BIO International Convention in San Diego from the 13th to the 16th of June Biophytis announces it will participate, represented by its CEO Stanislas Veillet and its Business Development Director Benoit Canolle, at the Biotechnology Innovation Organization (BIO) International Convention to be held in San Diego from the 13th…

MARCH 16, 2022

Biophytis announces its participation to a Virtual Workshop the development of Function promoting therapies for the elderly, organized by the National Institute on Aging based in Baltimore, USA. Dr Waly Dioh, Chief Clinical Operations Officer of Biophytis, will present the progress of its drug candidate and will meet with public and private players as well…